{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:46:22Z","timestamp":1771469182505,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.leukres.2011.01.029","type":"journal-article","created":{"date-parts":[[2011,2,19]],"date-time":"2011-02-19T04:39:23Z","timestamp":1298090363000},"page":"646-656","source":"Crossref","is-referenced-by-count":12,"title":["7-b, a novel amonafide analogue, cause growth inhibition and apoptosis in Raji cells via a ROS-mediated mitochondrial pathway"],"prefix":"10.1016","volume":"35","author":[{"given":"Bing","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuhong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2011.01.029_bib0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.leukres.2011.01.029_bib0010","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/sj.bjc.6601187","article-title":"Clinical use of rituximab in haematological malignancies","volume":"89","author":"Avivi","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.leukres.2011.01.029_bib0015","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","article-title":"Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells","volume":"79","author":"Dalla-Favera","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2011.01.029_bib0020","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1073\/pnas.79.24.7837","article-title":"Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells","volume":"79","author":"Taub","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2011.01.029_bib0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canlet.2004.10.043","article-title":"Conditionally MYC: insights from novel transgenic models","volume":"226","author":"Avranitis","year":"2005","journal-title":"J Cancer Lett"},{"key":"10.1016\/j.leukres.2011.01.029_bib0030","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1200\/JCO.1995.13.4.812","article-title":"Clinical significance of p53 mutation in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases","volume":"13","author":"Preudhomme","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2011.01.029_bib0035","first-page":"1431","article-title":"A mutant 21 cyclin-dependent kinase inhibitor from a Burkitt's lymphoma","volume":"55","author":"Bhaitia","year":"1995","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.leukres.2011.01.029_bib0040","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1101\/gad.10.9.1054","article-title":"p53: puzzle and paradigm","volume":"10","author":"Ko","year":"1996","journal-title":"Genes Dev"},{"key":"10.1016\/j.leukres.2011.01.029_bib0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1535-6108(02)00241-6","article-title":"Apoptosis-targeted therapies for cancer","volume":"3","author":"Reed","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2011.01.029_bib0050","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1021\/jm0308850","article-title":"New analogues of amonafide and elinafide, containing aromatic heterocycles: synthesis, antitumor activity, molecular modeling, and DNA binding properties","volume":"47","author":"Brana","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.leukres.2011.01.029_bib0055","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.1021\/jm0606793","article-title":"Synthesis and biological evaluation of new asymmetrical bisintercalators as potential antitumor drugs","volume":"49","author":"Antonini","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.leukres.2011.01.029_bib0060","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1021\/jm070315q","article-title":"2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin5-yl}carbamoyl)acetamide (UNBS3157),a novel nonhematotoxic naphthalimide derivative with potent antitumor activity","volume":"50","author":"VanQuaquebeke","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.leukres.2011.01.029_bib0065","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1021\/jm8009684","article-title":"Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone 4. Further investigation on the inner spacer","volume":"51","author":"Tumiatti","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.leukres.2011.01.029_bib0070","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1016\/j.bmc.2005.05.006","article-title":"Novel thiazonaphthalimides as efficient antitumor and DNA photocleaving agents: effects of intercalation, side chains, and substituent groups","volume":"13","author":"Li","year":"2005","journal-title":"Biorg Med Chem"},{"key":"10.1016\/j.leukres.2011.01.029_bib0075","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1021\/jm100025u","article-title":"A new class of naphthalimide-based antitumor agents that inhibit topoisomerase II and induce lysosomal membrane permeabilization and apoptosis","volume":"53","author":"Chen","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.leukres.2011.01.029_bib0080","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.yexmp.2008.02.002","article-title":"Curcumin induces apoptosis in HCT-116 human colon cancer cells in a p21-independent manner","volume":"84","author":"Jane","year":"2008","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.leukres.2011.01.029_bib0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ajmg.1398","article-title":"Mitochondria, oxygen free radicals, and apoptosis","volume":"106","author":"Raha","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.leukres.2011.01.029_bib0090","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3748\/wjg.15.1702","article-title":"Reactive oxygen species: a double-edged sword in oncogenesis","volume":"15","author":"Pan","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.leukres.2011.01.029_bib0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1196\/annals.1427.015","article-title":"The role of mitochondria in reactive oxygen species metabolism and signaling","volume":"1147","author":"Starkov","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.leukres.2011.01.029_bib0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00418-008-0461-4","article-title":"Reactive oxygen species in phagocytic leukocytes","volume":"130","author":"Robinson","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.leukres.2011.01.029_bib0105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev.pharmtox.44.101802.121851","article-title":"The role of oxidative stress in carcinogenesis","volume":"44","author":"Klaunig","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.leukres.2011.01.029_bib0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/35041687","article-title":"Oxidants, oxidative stress and the biology of ageing","volume":"408","author":"Finkel","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2011.01.029_bib0115","article-title":"B1, a novel naphthalimide-based DNA intercalator, induces cell cycle arre-st and apoptosis in HeLa cells via p53 activation","author":"Liang","year":"2010","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.leukres.2011.01.029_bib0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cbi.2007.08.010","article-title":"In vitro cytotoxic potential of Polyalthia longifolia on human cancer cell lines and induction of apoptosis through mitochondrial-dependent pathway in HL-60 cells","volume":"171","author":"Verma","year":"2008","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.leukres.2011.01.029_bib0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.canlet.2009.03.039","article-title":"M2-A induces apoptosis and G2-M arrest via inhibiting PI3K\/Akt pathway in HL60 cells","volume":"283","author":"Wang","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.leukres.2011.01.029_bib0130","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1016\/j.ejmech.2009.07.011","article-title":"Novel naphthalimide derivatives as potential apoptosis-inducing agents: design, synthesis and biological evaluation","volume":"44","author":"Wu","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.leukres.2011.01.029_bib0135","first-page":"223","article-title":"Overexpression of c-Myc inhibits p21WAF1\/CIP1 expression and induces S-phase entry in 12-Otetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer Cells","volume":"10","author":"Mitchell","year":"1999","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.leukres.2011.01.029_bib0140","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/371534a0","article-title":"Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair","volume":"371","author":"Li","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2011.01.029_bib0145","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/369574a0","article-title":"The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA","volume":"369","author":"Waga","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2011.01.029_bib0150","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.leukres.2007.07.017","article-title":"Amonafide, a topoisomerase II inhibitor, is unaffected by P-glycoprotein-mediated efflux","volume":"32","author":"Chau","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.01.029_bib0155","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/leu.2008.87","article-title":"Amonafide l-malate is not a substrate for multidrug resistance proteins in secondary acute myeloid leukemia","volume":"22","author":"Burcu","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.01.029_bib0160","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.leukres.2009.07.038","article-title":"Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemia","volume":"34","author":"Steven","year":"2010","journal-title":"Leukemia Res"},{"key":"10.1016\/j.leukres.2011.01.029_bib0165","first-page":"237","article-title":"Naphthalimides as anti-cancer agents: synthesis and biological activity","volume":"1","author":"Brana","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.leukres.2011.01.029_bib0170","first-page":"2304","article-title":"Phase I study of amonafide dosing based on acetylator phenotype","volume":"53","author":"Ratain","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2011.01.029_bib0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/gcc.2870030304","article-title":"Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment","volume":"3","author":"Offit","year":"1991","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2011.01.029_bib0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drup.2007.01.003","article-title":"Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy","volume":"10","author":"Maddika","year":"2007","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.leukres.2011.01.029_bib0185","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","article-title":"The p21 Cdkinte-racting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases","volume":"75","author":"Harper","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2011.01.029_bib0190","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.282.5393.1497","article-title":"Requirement for p53 and p21 to sustain G2 arrest after DNA damage","volume":"282","author":"Bunz","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.leukres.2011.01.029_bib0195","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1368-7646(03)00044-X","article-title":"Differential effects of cell cycle regulatory protein p21WAF1\/Cip1 on apoptosis and sensitivity to cancer chemotherapy","volume":"6","author":"Liu","year":"2003","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.leukres.2011.01.029_bib0200","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1152\/ajplung.00135.2006","article-title":"Downregulation of PCNA potentiates p21-mediated growth inhibition in response to hyperoxia","volume":"292","author":"Gehen","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.leukres.2011.01.029_bib0205","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1038\/sj.emboj.7601246","article-title":"Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+\/calcineurin signaling pathway","volume":"25","author":"Buchholz","year":"2006","journal-title":"J EMBO"},{"key":"10.1016\/j.leukres.2011.01.029_bib0210","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nature01119","article-title":"Myc suppression of the p21 (Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage","volume":"419","author":"Seoane","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2011.01.029_bib0215","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1073\/pnas.88.12.5413","article-title":"p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia","volume":"88","author":"Gaidano","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2011.01.029_bib0220","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood.V84.8.2412.2412","article-title":"p53 in hematologic malignancies","volume":"84","author":"Imamura","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.01.029_bib0225","first-page":"175","article-title":"Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis","volume":"11","author":"Hsu","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2011.01.029_bib0230","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.leukres.2011.01.029_bib0235","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0891-5849(00)00317-8","article-title":"Mitochondrial free radical generation, oxidative stress, and aging","volume":"29","author":"Cadenas","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.leukres.2011.01.029_bib0240","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0300-9084(02)01368-8","article-title":"Mitochondrial intermembrane junctional complexes and their involvement in cell death","volume":"84","author":"Crompton","year":"2002","journal-title":"Biochimie"},{"key":"10.1016\/j.leukres.2011.01.029_bib0245","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physrev.00013.2006","article-title":"Mitochondrial membrane permeabilization in cell death","volume":"87","author":"Kroemer","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.leukres.2011.01.029_bib0250","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.cdd.4401271","article-title":"Caspase-9 is activated in a cytochrome c-independent manner early during TNFalpha induced apoptosis in murine cells","volume":"10","author":"McDonnell","year":"2003","journal-title":"Cell Death Differ"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611000567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611000567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T14:33:33Z","timestamp":1592318013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212611000567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0145212611000567"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2011.01.029","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}